Shan Huang1, Yuan Li1, Ke Shi1, Yi Zhang1, Ying-kun Guo2, and Zhi-gang Yang1
1Radiology, West China Hospital, Chengdu, China, 2Radiology, West China Second University Hospital, Chengdu, China
Synopsis
We retrospectively included 100 cardiac
amyloidosis (CA) and 217 hypertrophic cardiomyopathy (HCM) patients, aiming to
elucidate the value of texture analysis (TA) in non-contrast T2-weighted CMR
images of these patients. After the texture features were extracted, machine learning
algorithms were used to select the optimal features. The results showed that TA
was feasible and reproducible for detecting myocardial tissue alterations and differentiating
CA from HCM, even in patients with similar hypertrophy. The radiomics model achieved
a comparable diagnostic capacity to late gadolinium enhancement (LGE). Thus, TA
might help eliminate the use of contrast agent in the diagnosis of these patients.
Introduction
Cardiac amyloidosis (CA) is a progressive
and infiltrative cardiomyopathy with poor prognosis1. In certain clinical scenarios, it can still be a challenge to
differentiate CA from hypertrophic cardiomyopathy (HCM), especially in patients
contraindicated to gadolinium contrast agent 2. However, CA patients frequently suffer from impaired renal
function, either due to amyloid deposition in the kidneys or reduced cardiac
output from heart failure (HF).
We hypothesized that texture features
extracted from routinely acquired non-contrast T2-weighted cardiac magnetic
resonance images (CMR) could provide great performance in differentiating CA
and HCM. Methods
In this retrospective study, 100 CA (58.5±10.7 years; 41 (41%) females) and 217 HCM (50.7±14.8 years, 101 (46.5%) females) patients who
underwent CMR scans were included. Texture analysis was performed on non-contrast
T2-weighted CMR scans using 3D Slicer based on the Pyradiomics library3. Regions of interest were delineated by two radiologists
independently on non-contrast T2-weighted imaging (T2WI). Stepwise dimension
reduction and texture feature selection based on reproducibility4, machine learning algorithms5,6, and correlation analyses7 were performed to select features. Both the CA and HCM groups were
randomly divided into a training dataset and a testing dataset (7:3). After the
TA model was established in the training set, the diagnostic performance of the
model was validated in the testing set and further validated in a subgroup of
patients with similar hypertrophy matched by LV mass index as well as age, sex
and maximum wall thickness (MWT). Statistical analysis during the construction
of the radiomics signature was performed in R (version 4.0.1; R Foundation for
Statistical Computing, Vienna, Austria)8 with RStudio (version 1.3.959; RStudio, Boston, Mass)9. Other statistical analyses were conducted with SPSS (Version 19;
IBM, Armonk, NY).Results
Demographic and clinical characteristics of
the included subjects were presented in Table 1. In total, 837 texture features were initially extracted. The multistep
texture feature selection and dimension reduction process (Figure 1) resulted 7 most important and independent texture
features used for model fitting (Figure 2).
TA model of the 7 selected features provided a diagnostic accuracy of 86.0%
(AUC=0.915; 95% CI: 0.879-0.951) in the training dataset and 79.2% (AUC=0.842;
95% CI: 0.759-0.924) in the testing dataset (Figure 3). The differential diagnostic accuracy in the similar
hypertrophy subgroup was 82.2% (AUC=0.864, 95% CI: 0.805-0.922) (Table 2). The significance of the difference
between the AUCs of the TA model and late gadolinium enhancement (LGE) was
verified by Delong’s test (p=0.996). All seven texture features showed
significant differences between CA and HCM (all p<0.001).Discussion
Texture analysis is a postprocessing method
to identify subtle tissue alterations and can be applied to standard and
routinely acquired clinical CMR sequences. It comprehensively and elaboratively
analyze the spatial distributions of pixel gray levels in images, which further
derives substantial quantitative texture features characterizing the underlying
tissue texture10.
The selected texture features of CA in our
study suggested that CA had finer textural texture than HCM on T2WI. And the
HCM group showed coarser texture. The possible reason for this might be
correlated with the more pronounced myocardial edema present in CA11. The coarse texture of HCM might reflect tissue inhomogeneity, such
as myocardial disarray and fibrosis. Thus, TA seemed to be a useful quantitative
tool for the identification of tissue alterations.
Texture features in combination with
robust mathematical models could represent reliable diagnostic tools12. Our study demonstrated that the optimal combination of texture
features had an accuracy of 86% for differentiating between CA and HCM. Because HCM often shows extremely and
heterogeneously increased wall thickness. We further validated the diagnostic
capacity of the TA model in patients with similar hypertrophy matched by LV
mass index. This subgroup analysis showed that the TA model still had a great
discriminative capacity with high sensitivity and specificity for CA and HCM.
LGE is of great value in the diagnosis and differentiation of CA and HCM in clinical
setting. However, the required administration of a gadolinium agent has limited
some patients from undergoing this examination. In our study, the TA model
constructed with texture features extracted from non-contrast T2WI achieved a
comparable result to LGE in discriminating CA from HCM. Thus, TA of T2WI might
help eliminate the need for contrast agent administration in these patients.Conclusion
Our study demonstrated that texture
analysis based on non-contrast T2-weighted images could feasibly differentiate
CA from HCM, even in patients with similar hypertrophy. The selected final
texture features could achieve a comparable diagnostic capacity to LGE.Acknowledgements
No acknowledgement found.References
1.
Falk Rodney H. Diagnosis and management
of the cardiac amyloidoses. Circulation. 2005;112(13):2047.
2.
Thibaud, Damy, Bruno, et al. Prevalence
and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in
patients with increased left ventricular wall thickness. Eur Heart J.
Published online 2016.
3.
van Griethuysen JJM, Fedorov A, Parmar
C, et al. Computational Radiomics System to Decode the Radiographic Phenotype. Cancer
Res. 2017;77(21):e104-e107. doi:10.1158/0008-5472.CAN-17-0339
4.
Khan JN, Singh A, Nazir SA, Kanagala P,
Gershlick AH, Mccann GP. Comparison of cardiovascular magnetic resonance
feature tracking and tagging for the assessment of left ventricular systolic
strain in acute myocardial infarction. Eur J Radiol. 2015;84(5):840-848.
5.
Kursa MB, Rudnicki WR. A deceiving
charm of feature selection: The microarray case study. In: Man-Machine
Interactions 2. Springer; 2011:145–152.
6.
Tibshirani R. Regression shrinkage and
selection via the lasso: a retrospective. J R Statal Soc Ser B Statal
Methodol. 2011;73(3).
7.
Kuhn M. Caret: classification and
regression training. ascl. Published online 2015:ascl–1505.
8.
Team RC, others. R: A Language and
Environment for Statistical Computing. Vienna, Austria; 2013.
9.
Team Rs, others. RStudio: integrated
development for R. RStudio Inc Boston MA URL Httpwww Rstudio Com.
2015;42:14.
10.
Cendes GCastellanolBonilhalMLif. Texture
analysis of medical images. Clin Radiol. Published online 2004.
11.
Kotecha T, Martinez-Naharro A, Treibel
TA, et al. Myocardial Edema and Prognosis in Amyloidosis. J Am Coll Cardiol.
2018;71(25):2919-2931. doi:10.1016/j.jacc.2018.03.536
12. Wang S,
Summers RM. Machine learning and radiology. Med Image Anal.
2012;16(5):933-951.